Ablynx NV

Technologiepark 21 Zwijnaarde
Gent, 9052
Belgium View Map >>

P: +32 9 262 00 00
F: +32 9 262 00 01
www.ablynx.com
Description
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference t... more

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Contact People at this company

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Contact People at this company
Revenue
84434
Employees
344

Industries

Biotechnology, Drug Manufacturing & Research, Business Services

Similar Companies

MediGene AG, MorphoSys AG, PAION AG, Trigen Ltd

Stock Market

EUR: ABLX

SIC Codes

2834, 8731

NAICS Codes

325412, 541711

Recently updated profiles at this company (289 contacts available)

Nancy Dhont
Junior Purchaser
Andreia Correia
Research Associate - Discovery
Sarah Lamoot
Associate Director Purchase
Anne Brochot
Principal Scientist, Pharmacometrics
Bjorn Kino
Study Manager
Ann Brige
Team Leader
Eline Dejonckheere
Scientist - Study Monitor Pharmacology
Sofie Poelmans
Senior Scientist Bioanalytics and Immunogenicity
Guido Gielen
Vice President Human Resources
Ortwin Van de Vyver
Associate Scientist - Pharmacology PD-
City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory